Company Focus

Amgen

Latest Amgen News

Big pharma aggregate revenue up 7.9% in 2024
Pharmaceutical
As many as 19 of the top 20 publicly-traded global biopharma companies reported revenue growth in 2024, with an overall 7.9% year-on-year (YoY) increase in aggregate revenue to $880.4 billion, reveals GlobalData.   29 July 2025


Insights

Company Spotlight

Latest News & Features of interest to Amgen

Latest In Brief for Amgen

Pharmaceutical
Johnson & Johnson has announced the submission of an extension of indication application to the European Medicines Agency (EMA) seeking approval of Akeega (niraparib/abiraterone acetate) with prednisone or prednisolone for the treatment of adults with metastatic hormone-sensitive prostate cancer (mHSPC) and homologous recombination repair (HRR) gene alterations.   3 July 2025

Latest Relevant Ones To Watch News


More in M&A >


Relevant Ones to Watch Companies

Reset all filters
Refine Search